Item Type | Name |
Concept
|
Uterine Neoplasms
|
Academic Article
|
Role of vitamin D in uterine fibroid biology.
|
Academic Article
|
Vitamin D3 Inhibits Wnt/ß-Catenin and mTOR Signaling Pathways in Human Uterine Fibroid Cells.
|
Academic Article
|
Vitamin D and uterine fibroids: preclinical evidence is in; time for an overdue clinical study!
|
Academic Article
|
Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas.
|
Academic Article
|
Towards non-surgical therapy for uterine fibroids: catechol-O-methyl transferase inhibitor shrinks uterine fibroid lesions in the Eker rat model.
|
Academic Article
|
Gene therapy and uterine leiomyoma: a review.
|
Academic Article
|
Uterine Fibroids: Burden and Unmet Medical Need.
|
Academic Article
|
Expanding upon the Human Myometrial Stem Cell Hypothesis and the Role of Race, Hormones, Age, and Parity in a Profibroid Environment.
|
Academic Article
|
Adenovirus-mediated delivery of a dominant-negative estrogen receptor gene in uterine leiomyoma cells abrogates estrogen- and progesterone-regulated gene expression.
|
Academic Article
|
Berberine Inhibits Uterine Leiomyoma Cell Proliferation via Downregulation of Cyclooxygenase 2 and Pituitary Tumor-Transforming Gene 1.
|
Academic Article
|
Adipocytes enhance the proliferation of human leiomyoma cells via TNF-a proinflammatory cytokine.
|
Academic Article
|
1,25-dihydroxyvitamin D3 regulates expression of sex steroid receptors in human uterine fibroid cells.
|
Academic Article
|
Racial and ethnic differences in the pathogenesis and clinical manifestations of uterine leiomyoma.
|
Academic Article
|
Identification of Polycomb Group Protein EZH2-Mediated DNA Mismatch Repair Gene MSH2 in Human Uterine Fibroids.
|
Academic Article
|
Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial.
|
Academic Article
|
Ethnic distribution of estrogen receptor-alpha polymorphism is associated with a higher prevalence of uterine leiomyomas in black Americans.
|
Academic Article
|
Uterine fibroids in menopause and perimenopause.
|
Academic Article
|
Silencing Med12 Gene Reduces Proliferation of Human Leiomyoma Cells Mediated via Wnt/ß-Catenin Signaling Pathway.
|
Academic Article
|
Uterine fibroids are characterized by an impaired antioxidant cellular system: potential role of hypoxia in the pathophysiology of uterine fibroids.
|
Academic Article
|
Memy I: a novel murine model for uterine leiomyoma using adenovirus-enhanced human fibroid explants in severe combined immune deficiency mice.
|
Academic Article
|
Nicotinamide adenine dinucleotide phosphate oxidase is differentially regulated in normal myometrium versus leiomyoma.
|
Academic Article
|
Stro-1/CD44 as putative human myometrial and fibroid stem cell markers.
|
Academic Article
|
The Selective Progesterone Receptor Modulator Ulipristal Acetate Inhibits the Activity of the Glucocorticoid Receptor.
|
Academic Article
|
Molecular genetics and racial disparities of uterine leiomyomas.
|
Academic Article
|
Antiproliferative and proapoptotic effects of epigallocatechin gallate on human leiomyoma cells.
|
Academic Article
|
1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model.
|
Academic Article
|
Estrogen metabolite 2-methoxyestradiol induces apoptosis and inhibits cell proliferation and collagen production in rat and human leiomyoma cells: a potential medicinal treatment for uterine fibroids.
|
Academic Article
|
Mediator Kinase Disruption in MED12-Mutant Uterine Fibroids From Hispanic Women of South Texas.
|
Academic Article
|
A Preliminary Study: Human Fibroid Stro-1+/CD44+ Stem Cells Isolated From Uterine Fibroids Demonstrate Decreased DNA Repair and Genomic Integrity Compared to Adjacent Myometrial Stro-1+/CD44+ Cells.
|
Academic Article
|
1,25-dihydroxyvitamin d3 reduces extracellular matrix-associated protein expression in human uterine fibroid cells.
|
Academic Article
|
Burden, Prevalence, and Treatment of Uterine Fibroids: A Survey of U.S. Women.
|
Academic Article
|
Molecular Bio-Imaging Probe for Non-Invasive Differentiation Between Human Leiomyoma Versus Leiomyosarcoma.
|
Academic Article
|
Gene therapy of uterine leiomyomas: adenovirus-mediated expression of dominant negative estrogen receptor inhibits tumor growth in nude mice.
|
Academic Article
|
Oxidative stress: a key regulator of leiomyoma cell survival.
|
Academic Article
|
Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells.
|
Academic Article
|
Successes and failures of uterine leiomyoma drug discovery.
|
Academic Article
|
Simvastatin and uterine fibroids: opportunity for a novel therapeutic option.
|
Academic Article
|
1,25 Dihydroxyvitamin D3 Enhances the Antifibroid Effects of Ulipristal Acetate in Human Uterine Fibroids.
|
Academic Article
|
Targeted Adenoviral Vector Demonstrates Enhanced Efficacy for In Vivo Gene Therapy of Uterine Leiomyoma.
|
Academic Article
|
Uterine Leiomyoma: New Perspectives on an Old Disease.
|
Academic Article
|
Origin of Uterine Fibroids: Conversion of Myometrial Stem Cells to Tumor-Initiating Cells.
|
Academic Article
|
Uterine Fibroids: Bridging Genomic Defects and Chronic Inflammation.
|
Academic Article
|
Novel MED12 gene somatic mutations in women from the Southern United States with symptomatic uterine fibroids.
|
Academic Article
|
Hypovitaminosis D and high serum transforming growth factor beta-3: important biomarkers for uterine fibroids risk.
|
Academic Article
|
Potential nonhormonal therapeutics for medical treatment of leiomyomas.
|
Academic Article
|
Berberine inhibits the proliferation of human uterine leiomyoma cells.
|
Academic Article
|
Hormonal regulation of catechol-O-methyl transferase activity in women with uterine leiomyomas.
|
Academic Article
|
Vitamin D inhibits proliferation of human uterine leiomyoma cells via catechol-O-methyltransferase.
|
Academic Article
|
Novel effects of simvastatin on uterine fibroid tumors: in vitro and patient-derived xenograft mouse model study.
|
Academic Article
|
Non-coding RNAs: an important regulatory mechanism in pathogenesis of uterine fibroids.
|
Academic Article
|
Endocrine disruptor exposure during development increases incidence of uterine fibroids by altering DNA repair in myometrial stem cells.
|
Academic Article
|
Green tea extract inhibits proliferation of uterine leiomyoma cells in vitro and in nude mice.
|
Academic Article
|
Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups.
|
Academic Article
|
1,25-Dihydroxyvitamin D3 reduces TGF-beta3-induced fibrosis-related gene expression in human uterine leiomyoma cells.
|
Academic Article
|
Paricalcitol, a vitamin d receptor activator, inhibits tumor formation in a murine model of uterine fibroids.
|
Academic Article
|
Green tea extract inhibition of human leiomyoma cell proliferation is mediated via catechol-O-methyltransferase.
|
Academic Article
|
Medical treatment of uterine leiomyoma.
|
Academic Article
|
Gene therapy targeting leiomyoma: adenovirus-mediated delivery of dominant-negative estrogen receptor gene shrinks uterine tumors in Eker rat model.
|
Academic Article
|
Targeting adenoviral vectors for enhanced gene therapy of uterine leiomyomas.
|
Academic Article
|
Estrogen Receptors and Signaling in Fibroids: Role in Pathobiology and Therapeutic Implications.
|
Academic Article
|
Gene therapy of uterine leiomyoma: adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir treatment inhibits growth of human and rat leiomyoma cells in vitro and in a nude mouse model.
|
Academic Article
|
Magnetic nanoparticles as a new approach to improve the efficacy of gene therapy against differentiated human uterine fibroid cells and tumor-initiating stem cells.
|
Academic Article
|
Endocrine-disrupting chemicals and uterine fibroids.
|
Academic Article
|
Ulipristal Acetate for Treatment of Symptomatic Uterine Leiomyomas: A Randomized Controlled Trial.
|
Academic Article
|
Uterine fibroid therapy: the pharmacokinetic considerations.
|
Academic Article
|
The Mechanism and Function of Epigenetics in Uterine Leiomyoma Development.
|
Academic Article
|
H19 lncRNA identified as a master regulator of genes that drive uterine leiomyomas.
|
Academic Article
|
Towards fibroid gene therapy: adenovirus-mediated delivery of herpes simplex virus 1 thymidine kinase gene/ganciclovir shrinks uterine leiomyoma in the Eker rat model.
|
Academic Article
|
Developmental Exposure to Endocrine Disruptors Expands Murine Myometrial Stem Cell Compartment as a Prerequisite to Leiomyoma Tumorigenesis.
|
Academic Article
|
Vitamins and Uterine Fibroids: Current Data on Pathophysiology and Possible Clinical Relevance.
|
Academic Article
|
Non-hormonal mediators of uterine fibroid growth.
|
Academic Article
|
The role of endocrine-disrupting chemicals in uterine fibroid pathogenesis.
|
Academic Article
|
The Significance of Measuring Vitamin D Serum Levels in Women with Uterine Fibroids.
|
Academic Article
|
Targeting Hedgehog Pathway and DNA Methyltransferases in Uterine Leiomyosarcoma Cells.
|
Academic Article
|
Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy.
|
Academic Article
|
Proteogenomic landscape of uterine leiomyomas from hereditary leiomyomatosis and renal cell cancer patients.
|
Academic Article
|
Summary of the Proceedings of the Basic Science of Uterine Fibroids Meeting: New Developments February 28, 2020.
|
Academic Article
|
Simvastatin modulates estrogen signaling in uterine leiomyoma via regulating receptor palmitoylation, trafficking and degradation.
|
Academic Article
|
Reduction of Heavy Menstrual Bleeding in Women Not Designated as Responders to Elagolix Plus Add Back Therapy for Uterine Fibroids.
|
Academic Article
|
Current approaches to overcome the side effects of GnRH analogs in the treatment of patients with uterine fibroids.
|
Academic Article
|
Evaluation of Hedgehog Pathway Inhibitors as a Therapeutic Option for Uterine Leiomyosarcoma Using the Xenograft Model.
|
Academic Article
|
Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment.
|
Academic Article
|
Peptide ancestry informative markers in uterine neoplasms from women of European, African, and Asian ancestry.
|
Academic Article
|
An evaluation of relugolix/estradiol/norethindrone acetate for the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.
|
Academic Article
|
Simvastatin inhibits stem cell proliferation in human leiomyoma via TGF-ß3 and Wnt/ß-Catenin pathways.
|
Academic Article
|
A Call-to-Action for Clinicians to Implement Evidence-Based Best Practices When Caring for Women with Uterine Fibroids.
|
Academic Article
|
Adverse childhood experiences and health-related quality of life among women undergoing hysterectomy for uterine leiomyoma.
|
Academic Article
|
Human Myometrial and Uterine Fibroid Stem Cell-Derived Organoids for Intervening the Pathophysiology of Uterine Fibroid.
|
Academic Article
|
Relugolix Combination Therapy for Uterine Leiomyoma-Associated Pain in the LIBERTY Randomized Trials.
|
Academic Article
|
The Functional Role and Regulatory Mechanism of Bromodomain-Containing Protein 9 in Human Uterine Leiomyosarcoma.
|
Academic Article
|
Targeting Class I Histone Deacetylases in Human Uterine Leiomyosarcoma.
|
Academic Article
|
Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials.
|
Academic Article
|
Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas.
|
Academic Article
|
Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials.
|
Academic Article
|
The Functional Role and Regulatory Mechanism of FTO m6A RNA Demethylase in Human Uterine Leiomyosarcoma.
|
Academic Article
|
A plain language summary of the safety of relugolix combination therapy and improvement in symptoms in women with uterine fibroids from the LIBERTY 1 and LIBERTY 2 studies.
|
Academic Article
|
Update on the Role and Regulatory Mechanism of Extracellular Matrix in the Pathogenesis of Uterine Fibroids.
|
Academic Article
|
EZH2 activates Wnt/ß-catenin signaling in human uterine fibroids, which is inhibited by the natural compound methyl jasmonate.
|
Academic Article
|
Progesterone Signaling and Uterine Fibroid Pathogenesis; Molecular Mechanisms and Potential Therapeutics.
|
Academic Article
|
Efficacy and safety of vilaprisan in women with uterine fibroids: data from the ASTEROID 3 randomized controlled trial.
|
Academic Article
|
A plain language summary of the long-term relugolix combination therapy study for uterine fibroids.
|
Academic Article
|
Epigenetic Modulation of Inflammatory Pathways in Myometrial Stem Cells and Risk of Uterine Fibroids.
|
Academic Article
|
Uterine Fibroids: A Podcast on Patient and Physician Perspectives on Medical Management and a New Medical Therapy (Relugolix Combination Therapy).
|
Academic Article
|
GnRH agonists and antagonists in therapy of symptomatic uterine fibroids - current roles and future perspectives.
|
Academic Article
|
LIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids.
|
Academic Article
|
The combination of natural compounds Crila and epigallocatechin gallate showed enhanced antiproliferative effects on human uterine fibroid cells compared with single treatments.
|
Academic Article
|
Relugolix combination therapy in Black/African American women with symptomatic uterine fibroids: LIBERTY Long-Term Extension study.
|
Academic Article
|
Current and Emerging Treatment Options for Uterine Fibroids.
|
Academic Article
|
Evidence-Based Approach for Secondary Prevention of Uterine Fibroids (The ESCAPE Approach).
|
Academic Article
|
Survivin-Sodium Iodide Symporter Reporter as a Non-Invasive Diagnostic Marker to Differentiate Uterine Leiomyosarcoma from Leiomyoma.
|
Academic Article
|
Management of Uterine Fibroids and Sarcomas: The Palermo Position Paper.
|
Academic Article
|
Empowering Strategies for Lifestyle Interventions, Diet Modifications, and Environmental Practices for Uterine Fibroid Prevention; Unveiling the LIFE UP Awareness.
|